How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,976 results for

Long-Acting Reversible Contraception

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Pregnancy Ambivalence and Long-Acting Reversible Contraceptive (LARC) Use Among Young Adult Women: A Qualitative Study (PubMed)

Pregnancy Ambivalence and Long-Acting Reversible Contraceptive (LARC) Use Among Young Adult Women: A Qualitative Study Many young adults are unclear about how much they want to have, or prevent having, a baby. However, pregnancy ambivalence is an underexamined factor in the uptake of long-acting reversible contraceptive (LARC) methods-IUDs and implants-the most effective methods available.In 2014, investigators conducted six focus groups and 12 interviews with 50 women aged 18-29 in Dane County (...) of wanting children perceived LARC methods as too "permanent," despite awareness of their reversibility. Third, age and life stage were important factors: Younger women and those attending school or beginning careers were more likely than others to consider these methods because they had clearer motivations to avoid pregnancy. Finally, relationship stage influenced receptiveness to LARC methods: Women in newer relationships were more receptive than were those in longer term relationships who imagined

Full Text available with Trip Pro

2017 Perspectives on sexual and reproductive health

82. Uptake of long-acting reversible contraceptive devices in Western region of The Gambia (PubMed)

Uptake of long-acting reversible contraceptive devices in Western region of The Gambia The contraceptive method has become an essential factor in the life of most women of reproductive age group; although it varies in different stages of their life course. The use of long acting reversible methods (LARC) is proposed as a strategy to reverse undesirable maternal health consequences in developing countries.To determine the uptake of long-acting reversible contraceptive in The Gambia.A community (...) based cross-sectional study of women attending family planning clinic were studied using intervieweradministered questionnaire which included information on socio-demographic factors, reproductive health and contraceptive use of the participants.About 89 % of study participants used long acting reversible contraceptive methods. Of the three commonly available long acting reversible contraceptive methods, Depo Provera was the most commonly used method; 78 of 141 (55.32%); followed by implants (43.3

Full Text available with Trip Pro

2017 African health sciences

83. Assessment of utilization of long acting reversible contraceptive and associated factors among women of reproductive age in Harar City, Ethiopia (PubMed)

Assessment of utilization of long acting reversible contraceptive and associated factors among women of reproductive age in Harar City, Ethiopia World health organization report indicated that, in 2013 alone, over 289,000 maternal death that resulted from pregnancy and delivery related complication were reported worldwide indicating a decline of 45% from 1990. The sub-Saharan Africa region alone accounted for 62% of maternal death followed by southern Asian country (24%). Provision of family (...) planning is one of the effective intervention that prevent unwanted and ill spaced pregnancy there by reducing maternal mortality and morbidity. Given that its effectiveness and, associated fewer visits to health facilities, LARC are very important in tackling maternal mortality and morbidity. However, little is known regarding its prevalence in eastern Ethiopia. Thus, this study aimed to assess utilization of long acting reversible contraceptives and associated factors among women of reproductive age

Full Text available with Trip Pro

2017 The Pan African medical journal

84. Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial. (PubMed)

Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial. This is the protocol for an ancillary study to the multicentre Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial, a three-arm randomised trial comparing the effects of depot medroxyprogesterone acetate (DMPA), the levonorgestrel (LNG) implant and the copper intrauterine device (IUD) on HIV incidence (...) (NCT02550067 pre-results). The ancillary study will compare other non-contraceptive effects of these three long-acting, reversible contraceptions about which there is little existing comparative evidence.Women randomised to IUD, DMPA and LNG implant (1:1:1) at one of the ECHO trial sites will be asked to participate in the ancillary study at the 1-month follow-up visit. Research staff will interview women that consent to participate at the 3-month follow-up visit. Primary outcomes are depression, sexual

Full Text available with Trip Pro

2017 BMJ open Controlled trial quality: uncertain

85. Immediate postpartum use of long-acting reversible contraceptives in low- and middle-income countries (PubMed)

Immediate postpartum use of long-acting reversible contraceptives in low- and middle-income countries Globally, data show that many women of reproductive age desire to use modern family planning methods. Many of these women do not have access to modern contraceptives, which is termed their 'unmet need' for contraception. In low- and middle-income countries where total fertility rates can be high and many women have undesired fertility, or wish to increase their inter-pregnancy intervals, access (...) to modern contraceptives is often inadequate. The puerperium is a unique time for interventions to offer modern contraceptive methods. Having just given birth, women may desire contraceptives to prevent short-interval pregnancy, or further pregnancy, altogether. In high-, middle-, and low-income countries there has been an increased interest in the placement of long-acting reversible contraceptives at or immediately after delivery, regardless of delivery mode. These methods can provide women with highly

Full Text available with Trip Pro

2017 Maternal health, neonatology and perinatology

86. Rapid Contraceptive Uptake and Changing Method Mix With High Use of Long-Acting Reversible Contraceptives in Crisis-Affected Populations in Chad and the Democratic Republic of the Congo (PubMed)

Rapid Contraceptive Uptake and Changing Method Mix With High Use of Long-Acting Reversible Contraceptives in Crisis-Affected Populations in Chad and the Democratic Republic of the Congo The global health community has recognized that expanding the contraceptive method mix is a programmatic imperative since (1) one-third of unintended pregnancies are due to method failure or discontinuation, and (2) the addition of a new method to the existing mix tends to increase total contraceptive use. Since (...) July 2011, CARE has been implementing the Supporting Access to Family Planning and Post-Abortion Care (SAFPAC) initiative to increase the availability, quality, and use of contraception, with a particular focus on highly effective and long-acting reversible methods-intrauterine devices (IUDs) and implants-in crisis-affected settings in Chad and the Democratic Republic of the Congo (DRC). This initiative supports government health systems at primary and referral levels to provide a wide range

Full Text available with Trip Pro

2016 Global Health: Science and Practice

87. Strengthening Postabortion Family Planning Services in Ethiopia: Expanding Contraceptive Choice and Improving Access to Long-Acting Reversible Contraception (PubMed)

Strengthening Postabortion Family Planning Services in Ethiopia: Expanding Contraceptive Choice and Improving Access to Long-Acting Reversible Contraception Where unmet need for the safest, most effective, and long-acting reversible contraceptives (LARCs) is very high, the health system and partners need to implement problem-solving, locally feasible, and comprehensive family planning delivery strategies. Because young and unmarried women are most at risk for unintended pregnancy and repeat (...) abortion due to poor access to contraceptive services, postabortion family planning (PAFP) is a key component in such strategies. In Southern Nations, Nationalities, and People's Region, Ethiopia, Ipas implemented health system strengthening efforts from fiscal year (FY) 2010 (July 2009 to June 2010) to FY 2014 (July 2013 to June 2014) to improve the quality of PAFP services and expand method choice in 101 public facilities. The intervention significantly improved PAFP uptake at the project sites

Full Text available with Trip Pro

2016 Global Health: Science and Practice

88. Choice of Postpartum Contraception: Factors Predisposing Pregnant Adolescents to Choose Less Effective Methods Over Long-Acting Reversible Contraception. (PubMed)

Choice of Postpartum Contraception: Factors Predisposing Pregnant Adolescents to Choose Less Effective Methods Over Long-Acting Reversible Contraception. The purposes were to determine contraceptive methods pregnant adolescents intend to use postpartum and to understand factors that predispose intention to use less effective birth control than long-acting reversible contraception (LARC).Participants were 247 pregnant minority adolescents in a prenatal program. Intention was assessed by asking (...) "Which of the following methods of preventing pregnancy do you intend to use after you deliver?" Multinomial logistic regression analysis was used to determine factors associated with intent to use nonhormonal (NH) contraception (male/female condoms, abstinence, withdrawal and no method) or short-/medium-acting hormonal (SMH) contraception (birth control pill, patch, vaginal ring, injectable medroxyprogesterone acetate) compared with LARC (implant and intrauterine device) postpartum.Twenty-three

2016 The Journal of Adolescent Health

89. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol. (PubMed)

Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol. The increased use of long-acting reversible contraceptives (LARCs), such as intrauterine devices and hormonal implants, has the potential to reduce unintended pregnancy and abortion rates. However, use of LARCs in Australia is very low, despite clinical practice guidance and statements by national and international (...) peak bodies advocating their increased use. This protocol paper describes the Australian Contraceptive ChOice pRojet (ACCORd), a cluster randomised control trial that aims to test whether an educational intervention targeting general practitioners (GPs) and establishing a rapid referral service are a cost-effective means of increasing LARC uptake.The ACCORd intervention is adapted from the successful US Contraceptive CHOICE study and involves training GPs to provide 'LARC First' structured

Full Text available with Trip Pro

2016 BMJ open Controlled trial quality: predicted high

90. Cohort study: Initiation of long-acting reversible contraceptive methods (IUDs and implant) at pregnancy termination reduces repeat abortion

Cohort study: Initiation of long-acting reversible contraceptive methods (IUDs and implant) at pregnancy termination reduces repeat abortion Initiation of long-acting reversible contraceptive methods (IUDs and implant) at pregnancy termination reduces repeat abortion | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please (...) see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Initiation of long-acting reversible contraceptive methods (IUDs and implant) at pregnancy termination reduces repeat

2013 Evidence-Based Medicine (Requires free registration)

91. Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods. (PubMed)

Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods. The Affordable Care Act (ACA) required most private insurance plans to cover contraceptive services without patient cost-sharing as of January 2013 for most plans. Whether the ACA's mandate has impacted long-acting reversible contraceptives (LARC) use is unknown.The aim of this article is to assess trends in LARC cost-sharing and uptake before and one year after implementation of the ACA's (...) contraceptive mandate.A retrospective cohort study using Truven Health MarketScan claims data from January 2010 to December 2013.Women aged 18-45 years with continuous insurance coverage with claims for oral contraceptive pills, patches, rings, injections, or LARC during 2010-2013 (N=3,794,793).Descriptive statistics were used to assess trends in LARC cost-sharing and uptake from 2010 through 2013. Interrupted time series models were used to assess the association of time, ACA, and time after the ACA

Full Text available with Trip Pro

2016 Medical Care

92. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. (PubMed)

Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. Measures of contraceptive effectiveness combine technology and user-related factors. Observational studies show higher effectiveness of long-acting reversible contraception compared with short-acting reversible contraception. Women who choose long-acting reversible contraception may differ in key ways from women who choose short (...) -acting reversible contraception, and it may be these differences that are responsible for the high effectiveness of long-acting reversible contraception. Wider use of long-acting reversible contraception is recommended, but scientific evidence of acceptability and successful use is lacking in a population that typically opts for short-acting methods.The objective of the study was to reduce bias in measuring contraceptive effectiveness and better isolate the independent role that long-acting

Full Text available with Trip Pro

2016 American Journal of Obstetrics and Gynecology Controlled trial quality: predicted high

93. Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission. (PubMed)

Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission. Progestin-only long-acting reversible contraceptives (LARCs) are increasingly popular among women seeking contraception; however, recent epidemiological studies suggest that systemically administered medroxyprogesterone acetate (MPA) may increase HIV acquisition. In order to determine the exact mechanisms underlying increases (...) in transmission specific to MPA use and to test safer, alternative contraceptive progestin types and delivery methods, in vitro modeling studies must be performed. To achieve this, it is imperative that accurate hormone concentrations be utilized when modeling progestin-mediated outcomes, as the down-stream effects are dose-dependent. The local concentrations of progestins to which the lower female genital tract tissues are exposed after initiation of LARCs are unknown, but they likely differ from peripheral

2019 PLoS ONE

94. Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices - ACOG Menu ▼ Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices Page Navigation ▼ Number 735, May 2018 (Replaces Committee Opinion Number 539, October 2012) Committee on Adolescent Health Care Long-Acting Reversible Contraception Work Group This Committee Opinion was developed (...) by the American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care and the Long-Acting Reversible Contraception Work Group in collaboration with Committee member Ashlyn H. Savage, MD and Sarah F. Lindsay, MD, on behalf of the Long-Acting Reversible Contraception Work Group. This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. This information should not be considered

2012 American College of Obstetricians and Gynecologists

95. Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system

Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system L Long-acting re ong-acting rev versible contr ersible contraception: aception: le lev vonorgestrel 13.5 onorgestrel 13.5 mg intr mg intrauterine deliv auterine delivery ery system system Evidence summary Published: 4 June 2014 nice.org.uk/guidance/esnm41 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in June 2014. See summaries (...) in Nelson et al. (2013) (n=1432): 10 pregnancies occurred over 3 years (0.33 pregnancies per 100 woman-years). The contraceptive failure rate was 0.4% in year 1 and 0.9% over 3 years, which is similar to failure rates seen with correct and consistent use of other methods of long- acting reversible contraception. Safety Safety In women using the levonorgestrel 13.5 mg intrauterine system in the study: 8 serious adverse events were reported (0.6%) including 3 ectopic pregnancies and 2 cases of pelvic

2014 National Institute for Health and Clinical Excellence - Advice

96. Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC)

Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC) L Long-acting re ong-acting rev versible contr ersible contraception: aception: subcutaneous depot medro subcutaneous depot medroxyprogesterone xyprogesterone acetate (DMP acetate (DMPA A-SC) -SC) Evidence summary Published: 28 January 2014 nice.org.uk/guidance/esnm31 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in January (...) that compared subcutaneous and Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC) (ESNM31) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 19intramuscular administration of DMPA over 2 years with an optional 1-year extension, and also evaluated the effect of DMPA on BMD (Kaunitz et al. 2009); the other 2 studies were 1-year non- comparative studies (Jain et al. 2004

2014 National Institute for Health and Clinical Excellence - Advice

97. Increasing Uptake of Long-Acting Reversible Contraceptives in Cambodia Through a Voucher Program: Evidence From a Difference-in-Differences Analysis (PubMed)

Increasing Uptake of Long-Acting Reversible Contraceptives in Cambodia Through a Voucher Program: Evidence From a Difference-in-Differences Analysis This article evaluates the use of modern contraceptives among poor women exposed to a family planning voucher program in Cambodia, with a particular focus on the uptake of long-acting reversible contraceptives (LARCs).We used a quasi-experimental study design and data from before-and-after intervention cross-sectional household surveys (conducted (...) a positive and significant association of the voucher program with LARC use. The greatest increases occurred among the poorest and least educated women.A family planning voucher program can increase access to and use of more effective long-acting methods among the poor by reducing financial and information barriers.© Bajracharya et al.

Full Text available with Trip Pro

2016 Global Health: Science and Practice

98. The Mayer Hashi Large-Scale Program to Increase Use of Long-Acting Reversible Contraceptives and Permanent Methods in Bangladesh: Explaining the Disappointing Results. An Outcome and Process Evaluation (PubMed)

The Mayer Hashi Large-Scale Program to Increase Use of Long-Acting Reversible Contraceptives and Permanent Methods in Bangladesh: Explaining the Disappointing Results. An Outcome and Process Evaluation Bangladesh has achieved a low total fertility rate of 2.3. Two-thirds of currently married women of reproductive age (CMWRA) want to limit fertility, and many women achieve their desired fertility before age 30. The incidence of unintended pregnancy and pregnancy termination is high, however (...) . Long-acting reversible contraceptives (LARCs), consisting of the intrauterine device and implant, and permanent methods (PM), including female sterilization and vasectomy, offer several advantages in this situation, but only 8% of CMWRA or 13% of method users use these methods.The Mayer Hashi (MH) program (2009-2013) aimed to improve access to and the quality of LARC/PM services in 21 of the 64 districts in Bangladesh. It was grounded in the SEED (supply-enabling environment-demand) Programming

Full Text available with Trip Pro

2016 Global Health: Science and Practice

99. Long-Acting Reversible Contraceptives: An Important Focus at the 2016 International Conference on Family Planning (PubMed)

Long-Acting Reversible Contraceptives: An Important Focus at the 2016 International Conference on Family Planning 27540117 2018 03 23 2018 03 23 2169-575X 4 Suppl 2 2016 08 11 Global health, science and practice Glob Health Sci Pract Long-Acting Reversible Contraceptives: An Important Focus at the 2016 International Conference on Family Planning. S1 10.9745/GHSP-D-16-00241 eng Introductory Journal Article 2016 08 18 United States Glob Health Sci Pract 101624414 2169-575X 0 Contraceptive Agents (...) , Female IM Congresses as Topic Contraception trends Contraceptive Agents, Female therapeutic use Family Planning Services trends Female Health Policy Humans Long-Acting Reversible Contraception trends Male Women's Rights 2016 8 20 6 0 2016 8 20 6 0 2018 3 24 6 0 epublish 27540117 GHSP-D-16-00241 10.9745/GHSP-D-16-00241 PMC4990154

Full Text available with Trip Pro

2016 Global Health: Science and Practice

100. The Tupange Project in Kenya: A Multifaceted Approach to Increasing Use of Long-Acting Reversible Contraceptives (PubMed)

The Tupange Project in Kenya: A Multifaceted Approach to Increasing Use of Long-Acting Reversible Contraceptives Long-acting reversible contraceptives (LARCs) are safe and highly effective, and they have higher continuation rates than short-acting methods. Because only a small percentage of sexually active women in Kenya use LARCs, the Tupange project implemented a multifaceted approach to increase uptake of LARCs, particularly among the urban poor. The project included on-site mentoring, whole (...) -site orientation, commodity security, quality improvement, and multiple demand-promotion and service-provision strategies, in the context of wide method choice. We report on activities in Nairobi between July 2011 and December 2014, the project implementation period.We used a household longitudinal survey of women of reproductive age to measure changes in the contraceptive prevalence rate (CPR) and other family planning-related variables. At baseline in July 2010, 2,676 women were interviewed

Full Text available with Trip Pro

2016 Global Health: Science and Practice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>